# Curcumin on NFE2L2 Gene Expression, Antioxidant Capacity and Renal Function According to rs35652124 in Diabetic Nephropathy

> **NCT03262363** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Unidad de Investigacion Medica en Enfermedades Renales** · enrollment: 176 (estimated)

## Conditions studied

- Chronic Kidney Diseases
- Diabetes Mellitus, Type 2
- Polymorphism

## Interventions

- **COMBINATION_PRODUCT:** Curcumin/NFE2L2 A>G
- **COMBINATION_PRODUCT:** Placebo/NFE2L2 A>G

## Key facts

- **NCT ID:** NCT03262363
- **Lead sponsor:** Unidad de Investigacion Medica en Enfermedades Renales
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-01
- **Primary completion:** 2019-02-28
- **Final completion:** 2019-04-30
- **Target enrollment:** 176 (ESTIMATED)
- **Last updated:** 2018-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03262363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03262363, "Curcumin on NFE2L2 Gene Expression, Antioxidant Capacity and Renal Function According to rs35652124 in Diabetic Nephropathy". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03262363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*